AARTI PHARMALABS
Back to Income Statement
|
AARTI PHARMALABS Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹2,115 Cr | ₹1,853 Cr | ₹1,945 Cr | ₹1,200 Cr | - |
What is the latest Revenue of AARTI PHARMALABS ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹2,115 Cr |
| Mar2025 | ₹1,853 Cr |
| Mar2024 | ₹1,945 Cr |
| Mar2023 | ₹1,200 Cr |
| Mar2022 | - |
How is Revenue of AARTI PHARMALABS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,115 Cr | 14.17 | |
| Mar2025 | ₹1,853 Cr | -4.76 | |
| Mar2024 | ₹1,945 Cr | 62.11 | |
| Mar2023 | ₹1,200 Cr | 0 | |
| Mar2022 | - | - | |
Compare Revenue of peers of AARTI PHARMALABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI PHARMALABS | ₹8,013.8 Cr | 8.7% | 8.2% | -7.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,437.0 Cr | -0.5% | -3% | 16% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,054.0 Cr | 1.6% | 9.3% | 54.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,842.0 Cr | 3.5% | 2.3% | 40.6% | Stock Analytics | |
| CIPLA | ₹111,565.0 Cr | 1.6% | -3.2% | -11.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,163.0 Cr | 5.8% | 3.2% | -8.3% | Stock Analytics | |
AARTI PHARMALABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI PHARMALABS | 8.7% |
8.2% |
-7.1% |
| SENSEX | 0.7% |
-3.9% |
-8.9% |
You may also like the below Video Courses